Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study

Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study

Abstract Background Several prolonged typhoid fever epidemics have been reported since 2010 throughout eastern and southern Africa, including Malawi, caused by multidrug-resistant Salmonella Typhi. The World Health Organization recommends the use of typhoid conjugate vaccines (TCVs) in outbreak sett...

Full description

Bibliographic Details
Main Authors: Maile T. Phillips, Marina Antillon, Joke Bilcke, Naor Bar-Zeev, Fumbani Limani, Frédéric Debellut, Clint Pecenka, Kathleen M. Neuzil, Melita A. Gordon, Deus Thindwa, A. David Paltiel, Reza Yaesoubi, Virginia E. Pitzer
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Infectious Diseases
Subjects:
Typhoid fever
Reactive vaccination
Preventive vaccination
Typhoid conjugate vaccines
Economic evaluation
Online Access:https://doi.org/10.1186/s12879-023-08105-2

Internet

https://doi.org/10.1186/s12879-023-08105-2

Similar Items